![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Mylan Laboratories Limited Hyderabad In, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Labetalol Hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2008-057 - Rev 04
This Chemical Type CEP, issued on July 17, 2013, remains in force until March 17, 2014, ensuring its reliability within the pharmaceutical industry.
Substance Number 923 associated with this CEP further emphasizes